Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration

Tuboi, Suely H; Brinkhof, Martin W G; Egger, Matthias; Stone, Roslyn A; Braitstein, Paula; Nash, Denis; Sprinz, Eduardo; Dabis, François; Harrison, Lee H; Schechter, Mauro (2007). Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration. Journal of acquired immune deficiency syndromes JAIDS, 45(1), pp. 52-9. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/QAI.0b013e318042e1c3

[img] Text
Tuboi JAcquirImmuneDeficSyndr 2007.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (204kB) | Request a copy

OBJECTIVES: To assess the frequency of and risk factors for discordant responses at 6 months on highly active antiretroviral therapy (HAART) in previously treatment-naive HIV patients from resource-limited countries. METHODS: The Antiretroviral Therapy in Low-Income Countries Collaboration is a network of clinics providing care and treatment to HIV-infected patients in Africa, Latin America, and Asia. Patients who initiated therapy between 1996 and 2004, were aged 16 years or older, and had a baseline CD4 cell count were included in this analysis. Responses were defined based on plasma viral load (PVL) and CD4 cell count at 6 months as complete virologic and immunologic (VR(+)IR(+)), virologic only (VR(+)IR(-)), immunologic only (VR(-)IR(+)), and nonresponse (VR(-)IR(-)). Multinomial logistic regression was used to assess the association between therapy responses and clinical and demographic variables. RESULTS: Of the 3111 patients eligible for analysis, 1914 had available information at 6 months of therapy: 1074 (56.1%) were VR(+)IR(+), 364 (19.0%) were VR(+)IR(-), 283 (14.8%) were (VR(-)IR(+)), and 193 (10.1%) were VR(-)IR(-). OF THE 3111 patients eligible for analysis, 1914 had available information at 6 months of therapy: 1074 (56.1%) were VRIR, 364 (19.0%) were VRIR, 283 (14.8%) were (VRIR), and 193 (10.1%) were VRIR. Compared with complete responders, virologic-only responders were older, had a higher baseline CD4 cell count, had a lower baseline PVL, and were more likely to have received a nonstandard HAART regimen; immunologic-only responders were younger, had a lower baseline CD4 cell count, had a higher baseline PVL, and were more likely to have received a protease inhibitor-based regimen. CONCLUSIONS: The frequency of and risk factors for discordant responses were comparable to those observed in developed countries. Longer follow-up is needed to assess the long-term impact of discordant responses on mortality in these resource-limited settings.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine

UniBE Contributor:

Brinkhof, Martin and Egger, Matthias

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0894-9255

ISBN:

17460471

Publisher:

Lippincott Williams & Wilkins

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:53

Last Modified:

11 Sep 2017 21:05

Publisher DOI:

10.1097/QAI.0b013e318042e1c3

PubMed ID:

17460471

Web of Science ID:

000245964000008

BORIS DOI:

10.7892/boris.22420

URI:

https://boris.unibe.ch/id/eprint/22420 (FactScience: 34600)

Actions (login required)

Edit item Edit item
Provide Feedback